Remodilins for airway remodeling and organ fibrosis
Julian Solway, Glencoe, IL (US); Nickolai Dulin, Chicago, IL (US); Diane Luci, Germantown, MD (US); David Maloney, Point of Rocks, MD (US); Chan Young Park, Belmont, MA (US); Jeffrey Fredberg, Newton, MA (US); David McCormick, Chicago, IL (US); and Ramaswamy Krishnan, Boston, MA (US)
Assigned to The University of Chicago, Chicago, IL (US); The United States of America, as Represented by the Secretary, Department of Health and Human Services, Bethesda, MD (US); President and Fellows of Harvard College, Cambridge, MA (US); IIT Research Institute, Chicago, IL (US); and Beth Israel Deaconess Medical Center Inc., Boston, MA (US)
Appl. No. 17/594,086
Filed by The University of Chicago, Chicago, IL (US); The United States of America, as Represented by the Secretary, Department of Health and Human Services, Bethesda, MD (US); President and Fellows of Harvard College, Cambridge, MA (US); IIT Research Institute, Chicago, IL (US); Beth Israel Deaconess Medical Center, Inc., Boston, MA (US); REGENTS OF THE UNIVERSITY OF MINNESOTA, Minneapolis, MN (US); and THE TRUSTEES OF PURDUE UNIVERSITY, Lafayette, IN (US)
